Joel Greenblatt Xeris Biopharma Holdings, Inc. Transaction History
Gotham Asset Management, LLC
- $16.1 Billion
- Q2 2025
A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Gotham Asset Management, LLC holds 32,766 shares of XERS stock, worth $302,757. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,766
Previous 16,232
101.86%
Holding current value
$302,757
Previous $89,000
71.91%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding XERS
# of Institutions
212Shares Held
90MCall Options Held
81.6KPut Options Held
57.6K-
Black Rock Inc. New York, NY10.3MShares$95.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.82MShares$90.7 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.84MShares$35.4 Million0.01% of portfolio
-
State Street Corp Boston, MA3.78MShares$35 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.65MShares$33.7 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $1.26B
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...